Refine by MP, party, committee, province, or result type.

Results 1-15 of 16
Sorted by relevance | Sort by date: newest first / oldest first

Health committee  Yes, we will take that back to the department. Thank you.

March 11th, 2021Committee meeting

Kimberly Elmslie

Health committee  From the point of view of vaccine safety, that is of course the highest priority for the Public Health Agency of Canada and our work with our colleagues at Health Canada.

March 11th, 2021Committee meeting

Kimberly Elmslie

Health committee  From that perspective, the safety system in Canada is very strong. We have a system that works with manufacturers, provinces and territories—

March 11th, 2021Committee meeting

Kimberly Elmslie

Health committee  Is the translation happening now?

March 11th, 2021Committee meeting

Kimberly Elmslie

Health committee  Thank you. If you don't mind, I'll just conclude quickly by saying that the safety system in Canada is very strong. It is watching very carefully for any safety signals and investigating any side effects that occur after administration of COVID-19 vaccines. Dr. Berthiaume—

March 11th, 2021Committee meeting

Kimberly Elmslie

Health committee  Thank you for the question. If I understand correctly, you are talking about the doses of vaccine that are coming into Canada and their use within the time frame. As Dr. Berthiaume pointed out, those doses are usable from the point of their arrival until their expiry date. We'r

March 11th, 2021Committee meeting

Kimberly Elmslie

Health committee  I do not have any information on that question. I will certainly be happy to get back to you with an answer, but I'm not aware of that.

March 11th, 2021Committee meeting

Kimberly Elmslie

Health committee  Of course, I will turn to Dr. Berthiaume in terms of the regulatory mandate, but as we know, Health Canada carries the mandate to regulate vaccines, and therefore looks at clinical trial data, data from the manufacturer, to understand and assess the quality, efficacy and safety o

March 11th, 2021Committee meeting

Kimberly Elmslie

Health committee  That's absolutely correct.

March 11th, 2021Committee meeting

Kimberly Elmslie

Health committee  What I would say to that is that data are being looked at by NACI and its experts and by Health Canada and their experts. From the point of view of the regulatory approach, Dr. Berthiaume can speak very well to that in the context of making decisions on the safety, efficacy and q

March 11th, 2021Committee meeting

Kimberly Elmslie

Health committee  I would say she's not wrong. I think it is important that we always strive for clarity and consistency in messaging. That is our objective, for sure. In this situation, as science is evolving, it is just sometimes not possible to be there at exactly the same time, and we need t

March 11th, 2021Committee meeting

Kimberly Elmslie

Health committee  Thank you very much. Maybe I'll start on that one. In the context of the vaccine strategy and the need to ensure there is a diverse strategy and availability of vaccines across the country, what's important is that we're getting vaccines to the provinces and territories and they

March 11th, 2021Committee meeting

Kimberly Elmslie

Health committee  We have been providing clear advice to Canadians through the work with the provinces and the territories. We'll continue to do that.

March 11th, 2021Committee meeting

Kimberly Elmslie

Health committee  There will be advice that changes over time. That is exactly what is happening as science becomes clearer and as more studies are reading out their results. We can expect to see changes in advice. It's really important to continue to provide as much information as clearly as we

March 11th, 2021Committee meeting

Kimberly Elmslie

Health committee  There is no one else speaking at this time, Mr. Chair.

March 11th, 2021Committee meeting

Kimberly Elmslie